HCA Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas

03
Preço $432.20
Capitalização de Mercado (MRQ) $94.20B
P/E (TTM) 14.5
EPS (TTM) $29.82
Receita (TTM) $78.01B
Rendimento div. 0.70%
ROE (TTM) -124.0%
Dívida/Capital (MRQ) -6.5
Intervalo 52 Semanas $354–$557

HCA Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização

04
intervalo
barras

A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.

Sobre HCA Healthcare, Inc. Common Stock Visão geral da empresa da Wikipedia

05 · wikidata

HCA Healthcare, Inc. (historically known as Hospital Corporation of America) is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors.

History

Early years

The Hospital Corporation of America (HCA) was founded in 1968 in Nashville, Tennessee, by Thomas F. Frist Sr., Thomas F. Frist Jr. and Jack C. Massey. The founders envisioned a company that would bring together hospitals to deliver patient-focused care while using the combined resources of the organization to strengthen hospitals and improve the practice of medicine. The company began with Nashville's Park View Hospital, which the elder Frist had founded in 1960 with other doctors and where he was chief executive.

The company included 11 hospitals when it filed its initial public offering on the New York Stock Exchange (NYSE) in 1969 and had 26 hospitals and 3,000 beds by the end of the year.

Growth and merger

The 1970s were characterized by rapid growth in the industry and for HCA Healthcare. In the early 1980s, the focus shifted to consolidation with HCA Healthcare acquiring General Care Corporation, General Health Services, Hospital Affiliates International and Health Care Corporation. By the end of 1981, the company operated 349 hospitals with more than 49,000 beds. Operating revenues had grown to $2.4 billion.

In 1987, HCA Healthcare, which had grown to operate 463 hospitals (255 owned and 208 managed), spun off HealthTrust, a privately owned, 104-hospital company. Believing its stock was undervalued, the company completed a $5.1 billion leveraged management buyout led by chairman Thomas F. Frist Jr. in 1988. HCA Healthcare re-emerged as a public company in 1992.

In February 1994, HCA Healthcare merged with Louisville, Kentucky-based Columbia Hospital Corporation, which earlier had acquired 73 hospitals of Galen Health Care from Humana,

to form Columbia/HCA Healthcare Corporation. Related names of note include HCA International and Health Corporation of America.

Columbia Hospital Corporation

In 1988, Rick Scott and Richard Rainwater each put up $125,000 in working capital in their new company, Columbia Hospital Corporation; they borrowed the remaining money needed to purchase two struggling hospitals in El Paso for $60 million. Then they acquired a neighboring hospital and shut it down. Within a year, the remaining two were doing much better. By the end of 1989, Columbia Hospital Corporation owned four hospitals with a total of 833 beds.

In 1992, Columbia made a stock purchase of Basic American Medical, which owned eight hospitals, primarily in southwestern Florida. In September 1993, Columbia did another stock purchase, worth $3.4 billion, of Galen Healthcare, which had been spun off by Humana Inc. several months earlier. At the time, Galen had approximately 90 hospitals. After the purchase, Galen stockholders had 82% of the stock in the combined company, with Scott still running the company.

Recent history

On November 17, 2006, HCA became a private company for the third time when it completed a merger in which the company was acquired by a private investor group including affiliates of Kohlberg Kravis Roberts and Bain Capital, together with Merrill Lynch and HCA Healthcare founder Thomas F. Frist Jr. The total transaction was valued at approximately $33 billion, making it the largest leveraged buyout in history at the time, eclipsing the 1989 buyout of RJR Nabisco.

In May 2010, HCA announced that the corporation would once again go public with an expected $4.6-billion IPO as HCA Holdings, Inc. In March 2011, HCA sold 126.2 million shares for $30 each, raising about $3.79 billion, at that time, the largest private-equity backed IPO in U.S. history. In May 2017, the corporation was renamed HCA Healthcare.

In December 2018, a historical marker was installed in the parking lot of HCA's Sarah Cannon Cancer Center in Nashville, formerly the location of HCA's first hospital, Park View Hospital.

In 2018, the company was ranked No. 67 in the 2019 Fortune 500 list of the largest United States corporations by total revenue.

In May 2021, the company finalized a deal with Google to develop healthcare algorithms using patient records. In August 2021, HCA announced a deal with venture capital firm General Catalyst to develop digital solutions to streamline workflows and improve patient care; as part of the deal, HCA sold its healthcare app development firm PatientKeeper to General Catalyst's portfolio company Commure.

In April 2022, HCA Healthcare announced a $1.5 million partnership with Florida International University's Nicole Wertheim college of Nursing and Health Sciences, to expand its facilities to address the national nursing shortage.

In October 2022, LCMC Health in partnership with Tulane University announced that it would acquire Tulane Medical Center, Lakeview Regional Medical Center, and Tulane Lakeside Hospital from HCA for $150 million pending regulatory approval.

In March 2024, it was announced HCA had completed the sale of West Hills Hospital and Medical Center and related assets in Los Angeles, California to UCLA Health, for an undisclosed amount.

Facilities

United States

As of 2024, HCA has 186 hospitals. They also report operating more than 2,400 additional sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics located in 20 U.S. states and in the United Kingdom. A significant portion of those hospitals are situated in Florida and Texas. As of 2022, HCA had 47 hospitals and 31 surgery centers in Florida, and 45 hospitals and 632 affiliated sites of care in Texas. In 2021, it announced plans to build 3 new hospitals in Florida. In 2022, The Dallas Morning News reported that HCA will build 5 new hospitals in Texas. They also have a strong presence in Tennessee, where it began. HCA had 13 hospitals there as of 2019.

Between 2003 and 2017, HCA did not enter any new markets. However, in July 2007, HCA sold its hospitals in Switzerland.

In 2017, HCA acquired the Memorial University Medical Center in Savannah, Georgia. That same year, they acquired three Houston, Texas, hospitals from Tenet Healthcare.

In 2019 they purchased Mission Health System which operates hospitals in North Carolina.

In January 2020, HCA Healthcare acquired Valify, a healthcare cost-management company. In May 2020, HCA acquired 49-bed Shands Starke (Fla.) Regional Medical Center and 25-bed Shands Live Oak (Fla.) Regional Medical Center from CHS. HCA is operating the two facilities as off-campus emergency departments of Lake City (Fla.) Medical Center and North Florida Regional Medical Center in Gainesville. Later that year, it signed an agreement to sell Garden Park Medical Center to Singing River Health System.

In 2021, HCA sold Redmond Regional Medical Center to AdventHealth for $635M, and four other Georgia hospitals to Piedmont Healthcare for $950 million. They also announced the acquisition of Meadows Regional Medical Center.

United Kingdom

HCA International, the UK arm of Hospital Corporation of America, "caters for around half of all private patients in London." The main hospital sites within the United Kingdom it operates include:

It opened urgent care walk-in centres at London Bridge Hospital and the Portland Hospital in March 2018. It claims that patients, on average, wait just seven minutes to see a nurse and 17 minutes to see a doctor. In February 2022, outsourced cleaning staff at London Bridge Hospital reported a lack of PPE, no access to sick pay, a lack of training and no prior warning about which rooms may be contaminated with the virus through the COVID-19 pandemic.

The Princess Grace Hospital specializes in breast cancer and surgery, aided by Kefah Mokbel and Nick Perry who, in 2005, founded The London Breast Institute.

The company opened The Harborne Hospital, a newly built private hospital located close to the Queen Elizabeth Hospital, Birmingham, in February 2024.

Significant areas of operation

Medical education

In recent years, HCA Healthcare has become a significant provider of clinical and medical education. It is the largest sponsor of graduate medical education programs in the U.S., with 56 teaching hospitals in 14 states, primarily in regions with a deficit of physician training programs. The company includes Research College of Nursing and Mercy School of Nursing, and has several advanced nursing simulation training centers. In early 2020, it completed the purchase of a majority stake in Galen College of Nursing, which operates 21 campuses in 12 states, offering Bachelor of Science and Associate of Science nursing degrees.

Controversies

Medicare billing practices lawsuit

In 1993, lawsuits were filed against HCA by former employees who alleged that the company had engaged in questionable Medicare billing practices. In 1997, with a federal investigation by the FBI, the IRS and the Department of Health and Human Services in its early stages, the Columbia/HCA board of directors forced Rick Scott to resign as chairman and CEO amid growing evidence that the company "had kept two sets of books, one to show the government and one with actual expenses listed." Thomas Frist, a co-founder of HCA and brother of U.S. Senator Bill Frist, returned to the company as CEO in 1997 and called on longtime friend and colleague Jack O. Bovender Jr. to help him turn the company around.

The federal probe culminated in 2003 with "the government receiving a total of over $2 billion in criminal fines and civil penalties for systematically defrauding federal health care programs." Columbia/HCA pleaded guilty to 14 felonies and admitted to systematically overcharging the government. The federal probe has been referred to as the longest and costliest investigation for health-care fraud in U.S. history.

2005 insider trading suit

In July 2005, U.S. Senator Bill Frist sold all of his HCA shares, which were held in a blind trust, two weeks before disappointing earnings sent the stock on a 9-point plunge. At the time, Frist was considering a run for president and said that he had sold his shares to avoid the appearance of a conflict of interest. When the company disclosed that other executives had also sold their shares during that same time, shareholders alleged that the company had made false claims about its profits to drive up the price, which then fell when the company reported disappointing financial results. Eleven of HCA's senior officers were sued for accounting fraud and insider trading. HCA settled the lawsuit in August 2007, agreeing to pay $20 million to the shareholders but admitting no wrongdoing, and no charges were brought.

COVID-19 PPE

During the COVID-19 pandemic in the United States, HCA hospital nurses and other workers spoke out about the lack of PPE. In April 2020, there was an outcry against HCA following the deaths of two nurses Celia Yap-Banago and Rosa Luna who worked at HCA hospitals in Kansas City and California and had contracted coronavirus, despite the alarm having been raised about the lack of PPE at work.

Mission Hospital Acquisition Complaints

On December 14, 2023, the North Carolina Attorney General sued HCA for violating the terms of an agreement that allowed HCA to purchase Mission Health.

On February 13, 2024, HCA Healthcare denied the allegations and asked a judge to dismiss the lawsuit by the Attorney General, and in return the hospital network filed a counterclaim against the Attorney General.

Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗

Wikidata ↗

setorHealth Care indústriaHealth Care funcionários230.000 paísUS

Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS

06
Receita$75.60B
2016-12-31 → 2025-12-31
EPS$28.33
2016-12-31 → 2025-12-31
Fluxo de caixa livre$7.69B
2016-12-31 → 2025-12-31
Margem líquida8.8%
2018-12-31 → 2025-12-31
Avaliação e Proporções 07–12

Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?

Métrica Tendência de 5 anos HCA média 5A Mediana de Pares Veredito
P/E (TTM) 14.5média 5A ≈13.8 ≈13.8 16.5 Subvalorizado
P/S (TTM) 1.2média 5A ≈1.2 ≈1.2 1.3 Subvalorizado
P/B (MRQ) -14.2média 5A ≈-39.2 ≈-39.2 · ·
EV / EBITDA 39.1média 5A ≈37.3 ≈37.3 19.6 Sobreavaliado
Preço / FCF (TTM) 15.7média 5A ≈14.6 ≈14.6 · ·
Preço / Fluxo de Caixa (TTM) 8.5média 5A ≈7.9 ≈7.9 9.7 Subvalorizado
EV / Revenue (EV / Receita) 1.8média 5A ≈1.8 ≈1.8 · ·
EV / FCF 17.9média 5A ≈21.8 ≈21.8 · ·
PEG Ratio ≈0.7 · · ·

A mediana dos pares é calculada em uma base padronizada por métrica e pode não corresponder sempre à base TTM/MRQ mostrada para esta ação.

valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana

Dividendos Rendimento, índice de pagamento, histórico de dividendos, CAGR de 5 anos

13
Dividend Yield0.70%
Índice de Pagamento10.0%
Pagamento Anualizado≈$3.12Pago trimestralmente
CAGR Dividendos 5 anos≈21.9%Por ação, ajustado por desdobramento
Sequência de Crescimento≈5Anos consecutivos de crescimento de dividendos
Data exValorMoedaRendimento
Set 16, 2026$0,78USD≈0.71%
Jun 16, 2026$0,78USD≈0.76%
Mar 17, 2026$0,78USD≈0.58%
Dez 15, 2025$0,72USD≈0.60%
Set 16, 2025$0,72USD≈0.71%
Jun 16, 2025$0,72USD≈0.75%
Mar 17, 2025$0,72USD≈0.82%
Dez 13, 2024$0,66USD≈0.84%
Set 16, 2024$0,66USD≈0.64%
Jun 14, 2024$0,66USD≈0.75%
Mar 14, 2024$0,66USD≈0.76%
Dez 13, 2023$0,60USD≈0.89%
Set 14, 2023$0,60USD≈0.90%
Jun 15, 2023$0,60USD≈0.81%
Mar 16, 2023$0,60USD≈0.90%
Dez 13, 2022$0,56USD≈0.92%
Set 15, 2022$0,56USD≈1.0%
Jun 15, 2022$0,56USD≈1.1%
Mar 16, 2022$0,56USD≈0.75%
Dez 13, 2021$0,48USD≈0.90%

Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados

14
Surpresa Média 7.9%
Próximo relatório Out 22, 2026
PeríodoRelatórioEPS ActualEPS est.Surpresa
30 de Junho de 2026 Jul 23, 2026 $7.62 $7.54 1.0%
31 de Março de 2026 $7.15 $7.21 -0.85%
31 de Dezembro de 2025 $8.14 $7.53 8.0%
30 de Setembro de 2025 $6.96 $5.77 20.6%
30 de Junho de 2025 $6.83 $6.31 8.2%
31 de Março de 2025 $6.45 $5.84 10.5%

Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa

15
Demonstração de Resultados 12
Métrica Tendência 2025202420232022202120202019201820172016
Revenue $75.60B$70.60B$64.97B$60.23B$58.75B$51.53B$51.34B$46.68B$43.61B$41.49B
SG&A Expense $548M$421M$353M$307M$337M$416M$370M$344M$340M$343M
Operating Expenses $65.77B$62.08B$57.26B$51.65B$48.92B$46.10B$46.09B$41.34B$39.23B$36.68B
Interest Expense $2.25B$2.06B$1.94B$1.74B$1.57B$1.58B$1.82B$1.75B$1.69B$1.71B
Pretax Income $9.83B$8.52B$7.71B$8.58B$9.83B$5.43B$5.24B$5.33B$4.38B$4.81B
Income Tax $2.05B$1.87B$1.61B$1.75B$2.11B$1.04B$1.10B$946M$1.64B$1.38B
Net Income $6.78B$5.76B$5.24B$5.64B$6.96B$3.75B$3.50B$3.79B$2.22B$2.89B
EPS (Basic) $28.70$22.27$19.25$19.43$21.52$11.10$10.27$10.90$6.12$7.53
EPS (Diluted) $28.33$22.00$18.97$19.15$21.16$10.93$10.07$10.66$5.95$7.30
Shares (Basic) 236,413,000258,603,000272,404,000290,348,000323,315,000338,274,000341,210,000347,297,000362,305,000383,591,000
Shares (Diluted) 239,495,000261,806,000276,412,000294,666,000328,752,000343,605,000348,226,000355,303,000372,221,000395,851,000
EBITDA $3.52B$3.31B$3.08B$2.97B$2.85B$2.72B$2.60B$2.28B$2.13B$1.97B
Balanço Patrimonial 22
Métrica Tendência 2025202420232022202120202019201820172016
Cash & Equivalents $1.04B$1.93B$935M$908M$1.45B$1.79B$621M$502M$732M$646M
Short-term Investments ·····$116M$147M$47M$54M$49M
Receivables $10.87B$10.75B$9.96B$8.89B$8.10B$7.05B$7.38B$6.79B$6.50B$5.83B
Inventory $1.65B$1.74B$2.02B$2.07B$1.99B$2.02B$1.85B$1.73B$1.57B$1.50B
Other Current Assets $2.22B$1.99B$2.01B$1.78B$2.01B$1.46B$1.35B$1.19B$1.17B$1.11B
Current Assets $15.78B$16.41B$14.93B$13.64B$13.54B$12.33B$11.20B$10.21B$9.98B$9.09B
PP&E (Net) $31.14B$29.41B$27.71B$25.57B$24.06B$23.20B$22.71B$19.76B$17.89B$16.35B
PP&E (Gross) $66.28B$62.51B$58.55B$54.76B$51.35B$49.32B$47.23B$42.97B$40.08B$37.05B
Accum. Depreciation $35.13B$33.10B$30.83B$29.18B$27.29B$26.12B$24.52B$23.21B$22.19B$20.70B
Other Non-current Assets $255M$230M$184M$298M$598M$546M$480M$690M$710M$1.07B
Total Assets $60.72B$59.51B$56.21B$52.44B$50.74B$47.49B$45.06B$39.21B$36.59B$33.76B
Accounts Payable $4.66B$4.28B$4.23B$4.24B$4.11B$3.54B$2.90B$2.58B$2.61B$2.32B
Current Liabilities $16.35B$15.18B$12.65B$9.90B$9.58B$8.70B$7.76B$7.57B$6.16B$5.83B
Capital Leases $1.85B$1.86B$1.90B$1.75B$1.75B$1.67B$1.50B···
Total Liabilities ······$45.62B$42.12B$41.59B$39.39B
Long-term Debt $44.28B$43.03B$39.59B$38.08B$34.58B$31.00B$33.72B$32.82B$33.06B$31.38B
Total Debt $41.60B$43.03B$39.59B$38.08B$34.58B$31.00B$33.72B$32.82B$33.06B$31.38B
Retained Earnings $-5.72B$-2.12B$-1.35B$-2.28B$-532M$777M$-2.35B$-4.57B$-6.53B$-6.97B
AOCI $-305M$-387M$-425M$-490M$-404M$-502M$-460M$-381M$-278M$-338M
Stockholders' Equity $-6.03B$-2.50B$-1.77B$-2.77B$-933M$572M$-2.81B$-4.95B$-6.81B$-7.30B
Liabilities + Equity $60.72B$59.51B$56.21B$52.44B$50.74B$47.49B$45.06B$39.21B$36.59B$33.76B
Shares Outstanding 224,605,100249,981,400265,537,300277,378,300305,476,800339,425,600338,445,600342,895,200350,091,600370,535,900
Fluxo de Caixa 17
Métrica Tendência 2025202420232022202120202019201820172016
D&A $3.52B$3.31B$3.08B$2.97B$2.85B$2.72B$2.60B$2.28B$2.13B$1.97B
Stock-based Comp $401M$360M$262M$341M$440M$362M$347M$268M$270M$251M
Amort. of Intangibles $12M$16M$20M$44M$25M$26M····
Other Non-cash $1.93B$1.08B$850M$-431M$-1.29B$2.40B$1.07B$461M$-3.53B$-2.67B
Operating Cash Flow $12.64B$10.51B$9.43B$8.52B$8.96B$9.23B$7.60B$6.76B$5.43B$5.65B
CapEx $4.94B$4.88B$4.74B$4.39B$3.58B$2.83B$4.16B$3.57B$3.02B$2.76B
Investing Cash Flow $-4.99B$-4.93B$-5.32B$-3.39B$-2.64B$-3.39B$-5.72B$-3.90B$-4.28B$-3.24B
Debt Issued $8.47B$7.50B$3.22B$6.00B$4.34B$2.70B$6.45B$2.00B$1.50B$5.40B
Net Debt Issued $1.08B$5.08B$2.31B$3.17B$475M$-737M$1.13B$296M$749M$925M
Stock Repurchased $10.07B$6.04B$3.81B$7.00B$8.21B$441M$1.03B$1.53B$2.05B$2.75B
Net Stock Activity $-10.07B$-6.04B$-3.81B$-7.00B$-8.21B$-441M$-1.03B$-1.53B$-2.05B$-2.75B
Dividends Paid $679M$690M$661M$653M$624M$153M$550M$487M$0·
Financing Cash Flow $-8.55B$-4.58B$-4.09B$-5.66B$-6.66B$-4.68B$-1.77B$-3.08B$-1.06B$-2.51B
Net Change in Cash $-893M$998M$27M$-543M$-342M$1.17B$119M$-230M$86M$-95M
Taxes Paid $1.74B$1.84B$1.39B$1.18B$2.18B$1.00B$849M$872M$1.21B$1.25B
Free Cash Flow $7.69B$5.64B$4.69B$4.13B$5.38B$6.40B$3.44B$3.19B$2.41B$2.89B
Levered FCF $5.91B$4.03B$3.16B$2.74B$4.15B$5.12B$2.00B$1.74B$1.35B$1.68B
Lucratividade 5
Métrica Tendência 2025202420232022202120202019201820172016
Net Margin 9.0%8.2%8.1%9.4%11.8%7.3%6.8%8.1%··
Pretax Margin 13.0%12.1%11.9%14.2%16.7%10.5%10.2%11.4%··
EBITDA Margin 4.7%4.7%4.7%4.9%4.9%5.3%5.1%4.9%··
ROA 11.3%10.0%9.7%10.9%14.2%8.1%8.3%10.0%6.3%8.7%
ROE -159.1%-269.6%-230.9%-305.0%-3853.7%-335.8%-90.4%-64.4%-31.4%-38.8%
Liquidez e Solvência 4
Métrica Tendência 2025202420232022202120202019201820172016
Current Ratio 1.01.11.21.41.41.41.41.31.61.6
Quick Ratio 0.70.80.91.01.01.01.11.01.21.1
Debt / Equity -6.9-17.2-22.3-13.8-37.154.2-12.0-6.6-4.9-4.3
LT Debt / Equity -6.9-15.3-21.0-13.6-36.853.8-12.0-6.5-4.8-4.3
Eficiência 2
Métrica Tendência 2025202420232022202120202019201820172016
Asset Turnover 1.31.21.21.21.21.11.21.2··
Receivables Turnover 7.06.86.97.17.87.17.27.0··
Por Ação 6
Métrica Tendência 2025202420232022202120202019201820172016
Book Value / Share $-26.83$-10.00$-6.68$-9.98$-3.05$1.69$-8.30$-14.44$-19.44$-19.71
Revenue / Share $315.66$269.68$235.04$204.41$178.71$149.98$147.42$131.37··
Cash Flow / Share $52.76$40.16$34.12$28.92$27.25$26.87$21.83$19.03$14.58$14.28
Cash / Share $4.63$7.73$3.52$3.27$4.75$5.28$1.83$1.46$2.09$1.74
Dividend / Share $2.88$2.64$2.40$2.24$1.92$0.43$1.60$1.40··
EPS (TTM) $28.33$22.00$18.97$19.15$21.16$10.93$10.07$10.66$5.95$7.30
Taxas de Crescimento 10
Métrica Tendência 2025202420232022202120202019201820172016
Revenue YoY 7.1%8.7%7.9%2.5%14.0%·····
Revenue CAGR 3Y 7.9%6.3%8.0%·······
Revenue CAGR 5Y 8.0%·········
EPS YoY 28.8%16.0%-0.94%-9.5%93.6%·····
EPS CAGR 3Y 13.9%1.3%20.2%·······
EPS CAGR 5Y 21.0%·········
Net Income YoY 17.8%9.9%-7.1%-18.9%85.3%·····
Net Income CAGR 3Y 6.3%-6.1%11.8%·······
Net Income CAGR 5Y 12.6%·········
Dividends Paid CAGR 5Y 34.7%·········
Avaliação (TTM) 17
Métrica Tendência 2025202420232022202120202019201820172016
Revenue TTM $75.60B$70.60B$64.97B$60.23B$58.75B$51.53B$51.34B$46.68B$43.61B$41.49B
Net Income TTM $6.78B$5.76B$5.24B$5.64B$6.96B$3.75B$3.50B$3.79B$2.22B$2.89B
Market Cap $104.86B$75.03B$71.88B$66.56B$78.48B$55.82B$50.03B$42.67B$30.75B$27.43B
Enterprise Value $145.42B$116.13B$110.53B$103.74B$111.61B$84.92B$82.98B$74.95B$63.02B$58.11B
P/E 16.513.614.312.512.115.014.711.714.810.1
P/S 1.41.11.11.11.31.11.00.90.70.7
P/B -17.4-30.0-40.5-24.1-84.197.6-17.8-8.6-4.5-3.8
P / Tangible Book ·····97.6····
P / Cash Flow 8.37.17.67.88.86.06.66.35.74.9
P / FCF 13.613.315.316.114.68.714.513.412.89.5
EV / EBITDA 41.335.135.934.939.131.232.032.929.629.6
EV / FCF 18.920.623.625.120.713.324.123.526.120.1
EV / Revenue 1.91.61.71.71.91.61.61.61.41.4
Dividend Yield 0.65%0.92%0.92%0.98%0.80%0.27%1.1%1.1%0.00%·
Earnings Yield 6.1%7.3%7.0%8.0%8.2%6.7%6.8%8.6%6.8%9.9%
Payout Ratio 10.0%12.0%12.6%11.6%9.0%4.1%15.7%12.9%··
Annual Payout $679M$690M$661M$653M$624M$153M$550M$487M$0·

Período mais recente à esquerda · valores nulos mostrados como ·

Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos

16
Métrica 2025-12-312024-12-312023-12-312022-12-312021-12-31
Receita $75.60B $70.60B $64.97B $60.23B $58.75B
Lucro líquido $6.78B $5.76B $5.24B $5.64B $6.96B
EPS Diluído $28.33 $22.00 $18.97 $19.15 $21.16

Investidores institucionais (13F) 1.474 declarantes · $57.2B total · Em 30 de Setembro de 2026

17

Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.

Detentores 1.474
Valor detido $57.2B
Novas posições 121
Posições encerradas 176
Atividade institucional — Q2 2026 vs trimestre anterior
Novas posições Posições encerradas Aumentou Diminuído Variação líquida de ações
121 (-64 vs trimestre anterior) 176 (+72 vs trimestre anterior) 458 (-25 vs trimestre anterior) 581 (+4 vs trimestre anterior) -627K

Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.

Instituição Valor Ações % de 13F rastreado Tipo
VANGUARD GROUP INC $6.870.392.526 14.716.173 12,00% Ações
BlackRock, Inc. $5.069.973.824 13.003.600 8,86% Ações
VANGUARD CAPITAL MANAGEMENT LLC $3.954.150.533 10.141.708 6,91% Ações
Sanders Capital, LLC $3.442.060.818 8.828.287 6,01% Ações
STATE STREET CORP $2.912.102.056 7.469.035 5,09% Ações
WELLINGTON MANAGEMENT GROUP LLP $1.835.396.649 4.707.473 3,21% Ações
GEODE CAPITAL MANAGEMENT, LLC $1.423.654.808 3.668.008 2,49% Ações
First Eagle Investment Management, LLC $1.284.907.912 3.295.565 2,24% Ações
VANGUARD PORTFOLIO MANAGEMENT LLC $1.057.704.509 2.712.828 1,85% Ações
MORGAN STANLEY $1.008.556.857 2.586.771 1,76% Ações
GOLDMAN SACHS GROUP INC $960.811.481 2.464.314 1,68% Ações
JPMORGAN CHASE & CO $896.800.955 2.285.832 1,57% Ações
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $861.456.107 2.209.485 1,50% Ações
NORGES BANK $836.457.140 2.145.367 1,46% Ações
Capital World Investors $770.864.224 1.977.121 1,35% Ações
Capital International Investors $747.403.041 1.916.947 1,31% Ações
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $709.859.997 1.500.000 1,24% Ações
NORTHERN TRUST CORP $666.150.458 1.708.560 1,16% Ações
FMR LLC $636.503.475 1.632.520 1,11% Ações
Invesco Ltd. $596.390.232 1.529.637 1,04% Ações
NORDEA INVESTMENT MANAGEMENT AB $553.702.529 1.429.943 0,97% Ações
BARCLAYS PLC $514.349.127 1.319.216 0,90% Ações
JANUS HENDERSON GROUP PLC $481.486.890 1.017.441 0,84% Ações
Crake Asset Management LLP $449.072.183 1.151.792 0,78% Ações
Metropolis Capital Ltd $430.915.307 910.564 0,75% Ações
Darsana Capital Partners LP $428.879.000 1.100.000 0,75% Ações
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $414.565.358 1.063.288 0,72% Ações
Legal & General Group Plc $410.992.402 1.054.124 0,72% Ações
FRANKLIN RESOURCES INC $399.958.688 1.025.824 0,70% Ações
Life Cycle Investment Partners Ltd $355.737.196 912.404 0,62% Ações
Bank of New York Mellon Corp $350.359.895 898.612 0,61% Ações
VANGUARD FIDUCIARY TRUST CO $339.685.814 871.235 0,59% Ações
ROYAL BANK OF CANADA $320.194.000 821.241 0,56% Ações
LYRICAL ASSET MANAGEMENT LP $255.015.742 654.071 0,45% Ações
BANK OF AMERICA CORP /DE/ $238.456.934 611.601 0,42% Ações
SCHRODER INVESTMENT MANAGEMENT GROUP $237.236.367 608.470 0,41% Ações
ROYAL LONDON ASSET MANAGEMENT LTD $235.649.908 604.401 0,41% Ações
PRINCIPAL FINANCIAL GROUP INC $234.827.401 602.290 0,41% Ações
UBS Group AG $230.953.291 592.355 0,40% Ações
National Pension Service $230.650.346 591.578 0,40% Ações
Russell Investments Group, Ltd. $206.832.565 530.340 0,36% Ações
Nuveen, LLC $199.595.109 511.927 0,35% Ações
Gobi Capital LLC $195.742.325 502.045 0,34% Ações
Cryder Capital Partners LLP $194.561.738 499.017 0,34% Ações
Allianz Asset Management GmbH $181.127.299 464.560 0,32% Ações
DEUTSCHE BANK AG\ $175.985.429 451.372 0,31% Ações
Swiss National Bank $172.097.446 441.400 0,30% Ações
DIMENSIONAL FUND ADVISORS LP $172.079.393 441.313 0,30% Ações
AustralianSuper Pty Ltd $159.635.782 409.438 0,28% Ações
HSBC HOLDINGS PLC $158.555.065 406.750 0,28% Ações

Mostrar todos os 1.474 proprietários institucionais →

Ativistas e proprietários de 5%+ 4 participações

18

Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.

Declarante Declarado Participação Status Propósito Declaração
Frisco Holding II, Hercules Holding II, Thomas F. Frist, Jr., Thomas F. Frist III, William R. Frist, Patricia F. Elcan 10 de Fevereiro de 2026 31,60% Declaração inicial · SEC
22 de Novembro de 2006 · Declaração inicial · SEC
Merrill Lynch Bank USA 11 de Setembro de 2006 · Declaração inicial · SEC
Frisco, Inc., Frisco Partners, Thomas F. Frist, Jr., Patricia Champion Frist, Patricia Frist Elcan, William Robert Frist, Thomas F. Frist III, Merrill Lynch Professional Clearing Corp., Merrill Lynch, Pierce, Fenner & Smith Incorporated, Merrill Lynch Financial Markets, Inc., Merrill Lynch International, Merrill Lynch & Co., Inc., Merrill Lynch Trust Company, FSB, Citigroup Inc.*, Bank of America Corporation, NB Holdings Corporation, NationsBanc Montgomery Holdings Corporation, Banc of America Securities LLC 4 de Agosto de 2006 · Declaração inicial · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Executivos da empresa 92 insiders · 54 diretores · 31 conselheiros

19
Investidor com informação privilegiada Função Última atividade Ações detidas Compras 12m Vendas 12m Líquido 12m
Samuel N Hazen CEO 10 de Fevereiro de 2026 F 64.842 0 7 $-21.483.290
O'Boyle Michael P President & CEO - Parallon 26 de Fevereiro de 2013 A 21.429 0 0 $0
Mike A Marks EVP and CFO 7 de Maio de 2026 G 46.576 0 0 $0
Bill B Rutherford CFO and EVP 16 de Fevereiro de 2024 F 22.251 0 0 $0
Russell K Harms CFO - Central Group 17 de Novembro de 2006 D 0 0 0 $0
Robert Samuel Hankins JR CFO-Outpatient Services Group 17 de Novembro de 2006 D 0 0 0 $0
Richard J Shallcross CFO - Western Group 17 de Novembro de 2006 D 0 0 0 $0
Jeffrey T Crudele CFO-Eastern Division 1 de Julho de 2005 F 13.865 0 0 $0
Erol R Akdamar Group President 12 de Novembro de 2024 M 6.843 0 0 $0
Timothy M Mcmanus Group President 31 de Julho de 2024 M 27.008 0 0 $0
Richard A Hammett Group President 16 de Fevereiro de 2024 F 17.936 0 0 $0
Charles J Hall Group President 11 de Novembro de 2022 M 202.443 0 0 $0
Bruce A Moore JR Group President - Service Line 11 de Novembro de 2022 S 30.807 0 0 $0
Paul W Rutledge Group President 31 de Dezembro de 2012 A 335.657 0 0 $0
Beverly B Wallace President - Parallon 2 de Novembro de 2011 M 144.714 0 0 $0
Charles Robert Evans President - Eastern Group 26 de Julho de 2006 A 62.173 0 0 $0
Marilyn B Tavenner President-Outpatient Svcs Grp 27 de Outubro de 2005 A 26.154 0 0 $0
Greg Roth President-Ambulatory Surgery 31 de Outubro de 2004 D 9.029 0 0 $0
Jay Grinney President-Eastern Group 7 de Maio de 2004 D 24.177 0 0 $0
Jon M Foster EVP and COO 10 de Fevereiro de 2026 F 23.062 0 0 $0
Michael R Mcalevey EVP & Chief Legal & Admin Off. 26 de Agosto de 2026 J 0 0 2 $-2.747.520
Jennifer Berres SVP & Chief Human Res. Officer 11 de Fevereiro de 2026 S 11.993 0 2 $-4.126.932
Christopher F. Wyatt SVP & Controller 11 de Fevereiro de 2026 S 44.379 0 1 $-2.020.000
Erica Rossitto SVP & Chief Nurse Executive 10 de Fevereiro de 2026 F 10.407 0 0 $0
Michael S. Cuffe EVP and Chief Clinical Officer 10 de Fevereiro de 2026 F 32.080 0 1 $-747.135
Sammie S Mosier SVP & Chief Nurse Executive 13 de Fevereiro de 2025 F 11.113 0 0 $0
Kathleen M Whalen SVP & Chief Ethics Officer 14 de Novembro de 2024 S 9.454 0 0 $0
Phillip G Billington SVP-Internal Audit Services 12 de Novembro de 2024 M 52.702 0 0 $0
Joseph A Sowell III SVP; Chief Development Officer 5 de Agosto de 2024 G 18.526 0 0 $0
Deborah M Reiner SVP - Mktg. & Communications 29 de Julho de 2024 S 3.510 0 0 $0
Kathryn A. Torres SVP-Payer Contracting & Align. 25 de Julho de 2024 S 17.755 0 0 $0
Jeffrey E. Cohen SVP-Government Relations 9 de Maio de 2024 S 5.185 0 0 $0
Chad J Wasserman SVP and CIO 18 de Março de 2024 M 1.576 0 0 $0
Martin P. Paslick SVP and CIO 12 de Abril de 2023 M 24.643 0 0 $0
Jane D. Englebright SVP and Chief Nursing Officer 9 de Novembro de 2021 S 0 0 0 $0
Robert A Waterman SVP & General Counsel 5 de Maio de 2021 S 50.062 0 0 $0
William J Morrow SVP - Finance and Treasurer 18 de Fevereiro de 2021 F 5.578 0 0 $0
Sandra L. Morgan SVP-Provider Relations 18 de Fevereiro de 2021 F 10.122 0 0 $0
Victor L Campbell SVP-Government Affairs 1 de Maio de 2019 A 194.145 0 0 $0
John M Steele SVP & Chief Human Res. Officer 25 de Fevereiro de 2019 M 84.157 0 0 $0
Milton R Johnson Chairman 25 de Fevereiro de 2019 M 881.823 0 0 $0
Ravi S. Chari SVP-Clinical Excellence 25 de Fevereiro de 2018 M 7.003 0 0 $0
Alan R Yuspeh SVP & Chief Ethics Officer 25 de Fevereiro de 2018 M 35.546 0 0 $0
Joseph N Steakley SVP-Internal Audit Services 25 de Fevereiro de 2018 M 65.199 0 0 $0
Jana Joustra Davis SVP - Mktg. & Corp. Affairs 23 de Maio de 2017 M 26.378 0 0 $0
David Gwin Anderson SVP - Finance 7 de Novembro de 2016 M 110.167 0 0 $0
Donald W Stinnett SVP & Controller 25 de Fevereiro de 2016 A 51.965 0 0 $0
Noel B Williams SVP and CIO 16 de Maio de 2012 M 299.030 0 0 $0
Jack O Bovender JR Chairman 6 de Outubro de 2009 A 188.340 0 0 $0
Carl V George SVP - Development 27 de Fevereiro de 2009 M 13.092 0 0 $0
Patricia T Lindler SVP - Government Programs 17 de Novembro de 2006 D 0 0 0 $0
Rosalyn S Elton SVP-Operations Finance 17 de Novembro de 2006 D 0 0 0 $0
Frank M Houser MD SVP-Quality & Medical Director 26 de Julho de 2006 A 46.145 0 0 $0
James A Fitzgerald JR SVP-Supply Chain Operations 29 de Janeiro de 2006 F 20.674 0 0 $0
Andrea B Smith Conselheiro 28 de Abril de 2026 A 4.666 0 0 $0
William R Frist Conselheiro 28 de Abril de 2026 A 13.740 0 0 $0
Wayne Joseph Riley Conselheiro 28 de Abril de 2026 A 15.029 0 0 $0
Hugh F Johnston Conselheiro 28 de Abril de 2026 A 4.475 0 0 $0
Thomas F Frist III Conselheiro 28 de Abril de 2026 A 15.858 0 0 $0
Michael W Michelson Conselheiro 28 de Abril de 2026 A 12.576 0 0 $0
Nancy Ann Deparle Conselheiro 28 de Abril de 2026 A 21.910 0 0 $0
John Chidsey Conselheiro 28 de Abril de 2026 A 1.305 0 0 $0
Robert J Dennis Conselheiro 29 de Abril de 2025 A 26.601 0 0 $0
Meg Crofton Conselheiro 29 de Abril de 2024 A 6.331 0 0 $0
Charles O Holliday JR Conselheiro 25 de Abril de 2022 A 18.955 0 0 $0
Geoffrey G Meyers Conselheiro 1 de Maio de 2019 A 39.153 0 0 $0
John W Rowe Conselheiro 1 de Maio de 2019 A 30.388 0 0 $0
Ann H Lamont Conselheiro 2 de Maio de 2018 A 17.661 0 0 $0
Jay O Light Conselheiro 3 de Maio de 2017 A 30.953 0 0 $0
Stephen G Pagliuca Conselheiro 5 de Dezembro de 2014 D 7.612.921 0 0 $0
Christopher R Gordon Conselheiro 1 de Novembro de 2013 D 30.003.156 0 0 $0
John Connaughton Conselheiro 1 de Novembro de 2013 D 30.003.156 0 0 $0
John H Mcarthur Conselheiro 17 de Novembro de 2006 D 0 0 0 $0
Kent C Nelson Conselheiro 17 de Novembro de 2006 D 0 0 0 $0
Magdalena Averhoff MD Conselheiro 17 de Novembro de 2006 D 0 0 0 $0
Glenda A Hatchett Conselheiro 17 de Novembro de 2006 D 0 0 0 $0
Frederick W Gluck Conselheiro 17 de Novembro de 2006 D 0 0 0 $0
Harold T Shapiro Conselheiro 17 de Novembro de 2006 D 0 0 0 $0
Michael C Armstrong Conselheiro 17 de Novembro de 2006 D 0 0 0 $0
Martin Feldstein Conselheiro 17 de Novembro de 2006 D 0 0 0 $0
Michael T Long Conselheiro 17 de Novembro de 2006 D 0 0 0 $0
ROYAL FRANK S Conselheiro 17 de Novembro de 2006 D 0 0 0 $0
Patricia F Elcan Detentor de 10% 6 de Fevereiro de 2026 J 36.557.141 0 0 $0
Frisco Holding II Detentor de 10% 6 de Fevereiro de 2026 J 36.557.141 0 0 $0
HERCULES HOLDING II, LLC Detentor de 10% 6 de Fevereiro de 2026 J 32.282.889 0 0 $0
Thomas F Frist JR Detentor de 10% 6 de Fevereiro de 2026 J 36.557.141 0 0 $0
Patricia C Frist Detentor de 10% 20 de Fevereiro de 2018 G 0 0 0 $0
KKR PEI GP LTD Detentor de 10% 1 de Abril de 2014 J 0 0 0 $0
Jonathan B Perlin · 2 de Agosto de 2021 S 44.348 0 0 $0
Juan Vallarino · 9 de Maio de 2016 M 61.036 0 0 $0
Richard M Bracken · 31 de Dezembro de 2014 F 82.499 0 0 $0
BANK OF AMERICA CORP /DE/ · 6 de Novembro de 2012 S 2.652.364 0 0 $0

Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto

Participação em ETFs Detido por 141 ETFs

20

O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.

Fundo Peso Unidades Em Fonte
BUL · Pacer Funds Trust 5,07% 16.545 NS 31 de Julho de 2026 N-PORT
IHF · iShares Trust 4,75% 147.977 SH 11 de Setembro de 2026 Diário
STNC · Hennessy Funds Trust 3,17% 7.315 NS 31 de Julho de 2026 N-PORT
PKW · Invesco Exchange-Traded Fund Trust 2,47% 97.151 SH 5 de Outubro de 2026 Diário
COWZ · Pacer Funds Trust 2,07% 960.711 NS 31 de Julho de 2026 N-PORT
WLTG · ETF Opportunities Trust 2,06% 3.942 NS 31 de Julho de 2026 N-PORT
RSPH · Invesco Exchange-Traded Fund Trust 1,67% 34.181 SH 5 de Outubro de 2026 Diário
RPG · Invesco Exchange-Traded Fund Trust 1,27% 58.310 SH 5 de Outubro de 2026 Diário
FLAG · Global X Funds 1,14% 48 NS 31 de Julho de 2026 N-PORT
FCPI · FIDELITY COVINGTON TRUST 1,03% 6.909 NS 31 de Julho de 2026 N-PORT
IYH · iShares Trust 1,01% 87.417 SH 11 de Setembro de 2026 Diário
SRHQ · Elevation Series Trust 0,94% 4.938 NS 31 de Julho de 2026 N-PORT
NEAR · iShares U.S. ETF Trust 0,92% 48.109.000 SH 11 de Setembro de 2026 Diário
FHLC · FIDELITY COVINGTON TRUST 0,91% 74.445 NS 31 de Julho de 2026 N-PORT
VHT · VANGUARD WORLD FUND 0,90% 470.451 SH 19 de Agosto de 2026 Diário
FXH · First Trust Exchange-Traded AlphaDE… 0,87% 22.725 NS 31 de Julho de 2026 N-PORT
DIVB · iShares Trust 0,87% 42.100 SH 11 de Setembro de 2026 Diário
NFRA · FlexShares Trust 0,84% 62.628 NS 31 de Julho de 2026 N-PORT
IXJ · iShares Trust 0,83% 81.708 SH 11 de Setembro de 2026 Diário
SPVM · Invesco Exchange-Traded Fund Trust 0,80% 2.483 SH 5 de Outubro de 2026 Diário
QUVU · Hartford Funds Exchange-Traded Trust 0,79% 3.522 NS 31 de Julho de 2026 N-PORT
BSCT · Invesco Exchange-Traded Self-Indexe… 0,78% 23.458.000 5 de Outubro de 2026 Diário
BSCS · Invesco Exchange-Traded Self-Indexe… 0,74% 25.787.000 5 de Outubro de 2026 Diário
CURE · Direxion Shares ETF Trust 0,72% 3.056 NS 31 de Julho de 2026 N-PORT
VFMF · VANGUARD WELLINGTON FUND 0,67% 12.075 SH 19 de Agosto de 2026 Diário
LGDX · Tidal Trust III 0,66% 2.345 NS 31 de Julho de 2026 N-PORT
VFVA · VANGUARD WELLINGTON FUND 0,55% 11.876 SH 19 de Agosto de 2026 Diário
BSCR · Invesco Exchange-Traded Self-Indexe… 0,50% 22.854.000 5 de Outubro de 2026 Diário
LSVD · ADVISORS' INNER CIRCLE FUND 0,46% 7.404 NS 31 de Julho de 2026 N-PORT
WLDR · Two Roads Shared Trust 0,43% 964 NS 31 de Julho de 2026 N-PORT
ROUS · Lattice Strategies Trust 0,42% 7.289 NS 31 de Julho de 2026 N-PORT
RWL · Invesco Exchange-Traded Fund Trust … 0,40% 92.347 SH 5 de Outubro de 2026 Diário
QLC · FlexShares Trust 0,39% 9.856 NS 31 de Julho de 2026 N-PORT
XOEF · iShares Trust 0,37% 194 SH 11 de Setembro de 2026 Diário
GSY · Invesco Actively Managed Exchange-T… 0,36% 14.000.000 5 de Outubro de 2026 Diário
UPSD · ETF Series Solutions 0,33% 972 NS 31 de Julho de 2026 N-PORT
BSCU · Invesco Exchange-Traded Self-Indexe… 0,33% 9.324.000 5 de Outubro de 2026 Diário
MGV · VANGUARD WORLD FUND 0,29% 97.604 SH 19 de Agosto de 2026 Diário
PFIG · Invesco Exchange-Traded Fund Trust … 0,28% 390.000 2 de Outubro de 2026 Diário
JPUS · J.P. Morgan Exchange-Traded Fund Tr… 0,28% 3.186 NS 31 de Julho de 2026 N-PORT
USXF · iShares Trust 0,26% 9.226 SH 11 de Setembro de 2026 Diário
IUS · Invesco Exchange-Traded Self-Indexe… 0,26% 5.813 SH 5 de Outubro de 2026 Diário
IWX · iShares Trust 0,23% 21.535 SH 11 de Setembro de 2026 Diário
VTV · VANGUARD INDEX FUNDS 0,23% 1.475.731 SH 19 de Agosto de 2026 Diário
JMOM · J.P. Morgan Exchange-Traded Fund Tr… 0,23% 14.235 NS 31 de Julho de 2026 N-PORT
MPLY · Strategy Shares 0,22% 87 NS 31 de Julho de 2026 N-PORT
EUSA · iShares, Inc. 0,21% 9.589 SH 11 de Setembro de 2026 Diário
RSP · Invesco Exchange-Traded Fund Trust 0,21% 461.214 SH 5 de Outubro de 2026 Diário
FTC · First Trust Exchange-Traded AlphaDE… 0,20% 6.420 NS 31 de Julho de 2026 N-PORT
SIZE · iShares Trust 0,19% 1.920 SH 11 de Setembro de 2026 Diário
DYNF · BlackRock ETF Trust 0,19% 183.934 SH 11 de Setembro de 2026 Diário
VMAX · Lattice Strategies Trust 0,19% 228 NS 31 de Julho de 2026 N-PORT
DSI · iShares Trust 0,19% 23.734 SH 11 de Setembro de 2026 Diário
ILCV · iShares Trust 0,18% 5.870 SH 10 de Setembro de 2026 Diário
IVW · iShares Trust 0,18% 331.185 SH 11 de Setembro de 2026 Diário
IUSG · iShares Trust 0,17% 136.713 SH 11 de Setembro de 2026 Diário
VOOG · VANGUARD ADMIRAL FUNDS 0,17% 115.334 SH 19 de Agosto de 2026 Diário
IWD · iShares Trust 0,17% 332.035 SH 11 de Setembro de 2026 Diário
VONV · VANGUARD SCOTTSDALE FUNDS 0,16% 90.157 SH 19 de Agosto de 2026 Diário
OMFL · Invesco Exchange-Traded Self-Indexe… 0,16% 17.773 SH 5 de Outubro de 2026 Diário
USMV · iShares Trust 0,16% 89.855 SH 11 de Setembro de 2026 Diário
ACWV · iShares, Inc. 0,15% 11.903 SH 11 de Setembro de 2026 Diário
EGLE · Global X Funds 0,15% 8 NS 31 de Julho de 2026 N-PORT
GLBL · Pacer Funds Trust 0,15% 4 NS 31 de Julho de 2026 N-PORT
PRF · Invesco Exchange-Traded Fund Trust 0,14% 33.331 SH 5 de Outubro de 2026 Diário
VOXP · Advisors Series Trust 0,13% 18 NS 31 de Julho de 2026 N-PORT
VRIG · Invesco Actively Managed Exchange-T… 0,12% 2.250.000 1 de Outubro de 2026 Diário
TOPC · iShares Trust 0,12% 95 SH 11 de Setembro de 2026 Diário
DGRO · iShares Trust 0,12% 120.741 SH 11 de Setembro de 2026 Diário
XVV · iShares Trust 0,11% 1.790 SH 11 de Setembro de 2026 Diário
QVML · Invesco Exchange-Traded Fund Trust … 0,11% 4.428 SH 5 de Outubro de 2026 Diário
IWL · iShares Trust 0,11% 5.786 SH 11 de Setembro de 2026 Diário
MGC · VANGUARD WORLD FUND 0,11% 31.176 SH 19 de Agosto de 2026 Diário
ACIO · ETF Series Solutions 0,11% 6.205 NS 31 de Julho de 2026 N-PORT
EVUS · iShares Trust 0,10% 934 SH 11 de Setembro de 2026 Diário
ADME · ETF Series Solutions 0,10% 751 NS 31 de Julho de 2026 N-PORT
XRMI · Global X Funds 0,10% 126 NS 31 de Julho de 2026 N-PORT
XCLR · Global X Funds 0,10% 9 NS 31 de Julho de 2026 N-PORT
XYLD · Global X Funds 0,10% 8.148 NS 31 de Julho de 2026 N-PORT
XTR · Global X Funds 0,10% 12 NS 31 de Julho de 2026 N-PORT
BKLC · BNY Mellon ETF Trust 0,10% 13.621 NS 31 de Julho de 2026 N-PORT
PBUS · Invesco Exchange-Traded Fund Trust … 0,10% 25.167 SH 5 de Outubro de 2026 Diário
VV · VANGUARD INDEX FUNDS 0,10% 181.364 SH 19 de Agosto de 2026 Diário
ESGV · VANGUARD WORLD FUND 0,10% 33.758 SH 19 de Agosto de 2026 Diário
IVV · iShares Trust 0,10% 1.957.485 SH 11 de Setembro de 2026 Diário
PTLC · Pacer Funds Trust 0,10% 7.919 NS 31 de Julho de 2026 N-PORT
FAD · First Trust Exchange-Traded AlphaDE… 0,10% 1.395 NS 31 de Julho de 2026 N-PORT
PBP · Invesco Exchange-Traded Fund Trust 0,10% 877 SH 5 de Outubro de 2026 Diário
ILCB · iShares Trust 0,10% 2.915 SH 11 de Setembro de 2026 Diário
EQAL · Invesco Exchange-Traded Fund Trust … 0,10% 1.794 SH 2 de Outubro de 2026 Diário
BBUS · J.P. Morgan Exchange-Traded Fund Tr… 0,09% 20.766 NS 31 de Julho de 2026 N-PORT
IYY · iShares Trust 0,09% 6.693 SH 11 de Setembro de 2026 Diário
VOTE · TCW ETF Trust 0,09% 2.545 NS 31 de Julho de 2026 N-PORT
FEX · First Trust Exchange-Traded AlphaDE… 0,09% 3.614 NS 31 de Julho de 2026 N-PORT
XYLG · Global X Funds 0,09% 147 NS 31 de Julho de 2026 N-PORT
DFUS · Dimensional ETF Trust 0,09% 46.791 NS 31 de Julho de 2026 N-PORT
IWB · iShares Trust 0,09% 103.721 SH 11 de Setembro de 2026 Diário
VOO · VANGUARD INDEX FUNDS 0,09% 4.034.357 SH 19 de Agosto de 2026 Diário
TOV · EA Series Trust 0,09% 607 NS 31 de Julho de 2026 N-PORT
SPUU · Direxion Shares ETF Trust 0,09% 586 NS 31 de Julho de 2026 N-PORT
ITOT · iShares Trust 0,09% 202.387 SH 11 de Setembro de 2026 Diário
ACVF · ETF Opportunities Trust 0,09% 337 NS 31 de Julho de 2026 N-PORT
GTOS · Invesco Actively Managed Exchange-T… 0,09% 104.000 5 de Outubro de 2026 Diário
QDPL · Pacer Funds Trust 0,09% 3.708 NS 31 de Julho de 2026 N-PORT
IWV · iShares Trust 0,09% 41.034 SH 11 de Setembro de 2026 Diário
DFAU · Dimensional ETF Trust 0,08% 25.516 NS 31 de Julho de 2026 N-PORT
CRBN · iShares Trust 0,08% 2.269 SH 11 de Setembro de 2026 Diário
TOK · iShares Trust 0,08% 451 SH 11 de Setembro de 2026 Diário
VTI · VANGUARD INDEX FUNDS 0,08% 4.930.930 SH 19 de Agosto de 2026 Diário
VONE · VANGUARD SCOTTSDALE FUNDS 0,08% 24.633 SH 19 de Agosto de 2026 Diário
VTHR · VANGUARD SCOTTSDALE FUNDS 0,08% 12.577 SH 19 de Agosto de 2026 Diário
PHDG · Invesco Actively Managed Exchange-T… 0,08% 116 SH 5 de Outubro de 2026 Diário
HCMT · Direxion Shares ETF Trust 0,08% 1.081 NS 31 de Julho de 2026 N-PORT
TILT · FlexShares Trust 0,08% 4.108 NS 31 de Julho de 2026 N-PORT
SPXL · Direxion Shares ETF Trust 0,07% 12.141 NS 31 de Julho de 2026 N-PORT
URTH · iShares, Inc. 0,07% 14.079 SH 11 de Setembro de 2026 Diário
ACWI · iShares Trust 0,06% 50.294 SH 11 de Setembro de 2026 Diário
HDUS · Lattice Strategies Trust 0,05% 275 NS 31 de Julho de 2026 N-PORT
VT · VANGUARD INTERNATIONAL EQUITY INDEX… 0,05% 125.729 SH 19 de Agosto de 2026 Diário
DCOR · Dimensional ETF Trust 0,05% 3.816 NS 31 de Julho de 2026 N-PORT
GLOF · iShares Trust 0,04% 202 SH 11 de Setembro de 2026 Diário
DUHP · Dimensional ETF Trust 0,04% 10.761 NS 31 de Julho de 2026 N-PORT
DFAC · Dimensional ETF Trust 0,02% 28.662 NS 31 de Julho de 2026 N-PORT
DFSU · Dimensional ETF Trust 0,02% 1.127 NS 31 de Julho de 2026 N-PORT
DXUV · Dimensional ETF Trust 0,01% 99 NS 31 de Julho de 2026 N-PORT
GTO · Invesco Actively Managed Exchange-T… 0,00% 42.000 30 de Setembro de 2026 Diário
CBLS · Elevation Series Trust -1,12% -1.546 NS 31 de Julho de 2026 N-PORT
BIV · VANGUARD BOND INDEX FUNDS · · 15 de Julho de 2026 Diário
BLV · VANGUARD BOND INDEX FUNDS · · 15 de Julho de 2026 Diário
BSV · VANGUARD BOND INDEX FUNDS · · 15 de Julho de 2026 Diário
BND · VANGUARD BOND INDEX FUNDS · · 15 de Julho de 2026 Diário
VUSB · VANGUARD BOND INDEX FUNDS · · 15 de Julho de 2026 Diário
VCRB · VANGUARD MALVERN FUNDS · · 15 de Julho de 2026 Diário
VPLS · VANGUARD MALVERN FUNDS · · 15 de Julho de 2026 Diário
VSDB · VANGUARD MALVERN FUNDS · · 15 de Julho de 2026 Diário
VCSH · VANGUARD SCOTTSDALE FUNDS · · 15 de Julho de 2026 Diário
VCIT · VANGUARD SCOTTSDALE FUNDS · · 15 de Julho de 2026 Diário
VCLT · VANGUARD SCOTTSDALE FUNDS · · 15 de Julho de 2026 Diário
VTC · VANGUARD SCOTTSDALE FUNDS · · 30 de Julho de 2026 Diário
BNDW · VANGUARD SCOTTSDALE FUNDS · · 30 de Julho de 2026 Diário
VCEB · VANGUARD WORLD FUND · · 30 de Julho de 2026 Diário

HCA Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta

21
classificação · 30 analistas COMPRA
Alvo mediano $450.00 +4,1%
6 20,0% Compra forte
11 36,7% Compra
12 40,0% Manter
1 3,3% Venda
0 0,0% Venda forte

Preço-alvo de 12 meses

22 analistas · 2026-10-05

Alvo médio $454.23 +5,1%

Agora Preço atual $432.20
Mín$380.00 Média$454.23 Máx$579.00

Comparação de pares (subindústria GICS) Métricas chave vs pares do setor

22

Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.

Ticker Capitalização de Mercado P/E Receita YoY Margem Líquida ROE Margem Bruta
HCA $104.86B 16.5 7.1% 9.0% -159.1% ·
THC $17.28B 12.8 3.1% 11.1% 56.4% ·
EHC $10.61B 19.2 10.5% 9.5% 25.1% ·
UHS · 9.4 9.7% 8.6% 21.4% ·
ENSG $10.12B 29.8 18.7% 6.8% 16.9% ·
PACS $6.01B 31.5 29.3% 3.6% 23.1% ·
CON $2.53B 15.1 13.9% 7.7% 49.8% ·
ACHC $1.28B -1.2 5.0% -33.3% -43.9% ·
BKD $2.57B -9.6 2.2% -8.2% -313.2% 26.2%
SNDA $612M -7.7 25.2% -18.6% -197.2% ·

Últimas notícias Notícias recentes mencionando esta empresa

23

Sinais de trading Sinais recentes de compra/venda com preço de entrada e relação risco/recompensa

25

Nenhum sinal aberto no momento — nenhum cartão está preenchido, e isso é honesto.

Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos

26

Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.

Sua seleção é salva e acompanha você em todos os tickers.

Fonte: SEC 10-Q arquivado Jul 28, 2026